ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QTNTU Quotient Limited - Unit (MM)

6.6105
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Quotient Limited - Unit (MM) NASDAQ:QTNTU NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.6105 0 01:00:00

Quotient Limited To Report Fourth Quarter and Fiscal Year 2014 Financial Results and Host Conference Call

08/05/2014 9:05pm

PR Newswire (US)


Quotient Limited - Unit (MM) (NASDAQ:QTNTU)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Quotient Limited - Unit (MM) Charts.

JERSEY, Channel Islands, May 8, 2014 /PRNewswire/ -- Quotient Limited ("Quotient") (Nasdaq: QTNTU), a commercial-stage diagnostics company, today announced that financial results for its fourth quarter and fiscal year ending March 31, 2014 will be released after market close on Monday, May 19th, 2014.

Quotient will host a conference call on Tuesday, May 20th at 8:30 a.m. Eastern Time to discuss its fourth quarter and fiscal year 2014 financial results.  Participants may access the call by dialing 1-877-407-9039 in the U.S. or 1-201-689-8470 outside the U.S. The call will be webcast live on the Company's website at www.quotientbd.com.

A replay of this conference call will be available through May 27th by dialing 1-877-870-5176 in the U.S. or 1-858-384-5517 outside the U.S. The replay access code is 13582560.

About Quotient Limited

Quotient Limited is an established, commercial-stage diagnostics company committed to reducing healthcare costs and improving patient care through the development and commercialization of innovative tests, currently focused on blood grouping and serological disease screening.  Quotient is developing its proprietary MosaiQ technology platform to offer a breadth of tests that is unmatched by any commercially available transfusion diagnostic instrument platform. The company's operations are based in Edinburgh, Scotland; Newtown, Pennsylvania; and Eysins, Switzerland.

SOURCE Quotient Limited

Copyright 2014 PR Newswire

1 Year Quotient Limited - Unit (MM) Chart

1 Year Quotient Limited - Unit (MM) Chart

1 Month Quotient Limited - Unit (MM) Chart

1 Month Quotient Limited - Unit (MM) Chart

Your Recent History

Delayed Upgrade Clock